85 Biggest Movers From Yesterday

Author: Lisa Levin | August 11, 2021 05:14am

Gainers

Fulcrum Therapeutics, Inc. (NASDAQ:FULC) jumped 125.3% to close at $18.77 on Tuesday after the company announced positive interim results from the Phase 1 trial with FTX-6058 in healthy adult volunteers.
Lightning eMotors, Inc. (NYSE:ZEV) shares climbed 81% to settle at $11.60 after the company reported a multi-year deal with Forest River for zero-emission bus technology, charging products and services. The deal is valued at up to $850 million.
SC Health Corporation (NYSE:SCPE) gained 53.1% to close at $16.00.
MediaCo Holding Inc. (NASDAQ:MDIA) climbed 36.3% to settle at $10.10.
Eliem Therapeutics, Inc. (NASDAQ:ELYM) gained 27.2% to close at $15.90 as the company priced its IPO at $12.50 per share.
Exagen Inc. (NASDAQ:XGN) jumped 24.6% to close at $12.77 following upbeat Q2 results.
Orphazyme A/S (NASDAQ:ORPH) gained 24.6% to close at $5.22.
Achilles Therapeutics plc (NASDAQ:ACHL) shares surged 22.1% to settle at $7.56 following Q2 results.
Fisker Inc. (NYSE:FSR) rose 21.6% to close at $18.27. Morgan Stanley resumed covered on the stock with a Buy rating and a $40 price target and set its bull-case scenario at $90.
Cortexyme, Inc. (NASDAQ:CRTX) gained 21.5% to settle at $120.21. Cortexyme recently announced Q2 earnings results and provided a business update.
3D Systems Corporation (NYSE:DDD) shares surged 21.5% to close at $34.44 after the company reported better-than-expected results for its second quarter on Monday.
ABVC BioPharma, Inc. (NASDAQ:ABVC) gained 18.4% to close at $3.73 on abnormally-high volume.
NexImmune, Inc. (NASDAQ:NEXI) surged 18.1% to settle at $12.46 following Q2 results.
Agrify Corporation (NASDAQ:AGFY) climbed 17.7% to settle at $26.62. Agrify is expected to report its financial results for the second quarter on August 12, 2021.
Angion Biomedica Corp. (NASDAQ:ANGN) gained 17.6% to close at $12.61. Angion Biomedica recently announced positive results from its Phase 1 study in healthy volunteers for ANG-3070 for fibrotic diseases.
BRP Group, Inc. (NASDAQ:BRP) gained 17.6% to close at $32.60 after the company reported better-than-expected Q2 results.
Albertsons Companies, Inc. (NYSE:ACI) rose 17.2% to close at $29.05 after the company said Sharon McCollam will join the Company as its President and Chief Financial Officer.
Nuwellis, Inc. (NASDAQ:NUWE) gained 16.8% to settle at $4.60 after reporting quarterly results.
Pioneer Power Solutions, Inc. (NASDAQ:PPSI) jumped 16.7% to close at $4.67.
Moving iMage Technologies, Inc. (NASDAQ:MITQ) rose 16.4% to settle at $3.83.
Myomo, Inc. (NYSE:MYO) gained 16.3% to close at $9.13 after reporting upbeat Q2 results.
Pixelworks, Inc. (NASDAQ:PXLW) jumped 15.4% to close at $3.52. Pixelworks is expected to release its Q2 financial results on August 10, 2021 after the closing bell.
Janus International Group, Inc. (NYSE:JBI) gained 14.8% to settle at $15.08 after the company reported Q2 sales of $174.18 million, up from $122.23 million year over year.
Cyxtera Technologies, Inc. (NASDAQ:CYXT) rose 14.6% to close at $9.74. The company recently announced Q2 results.
Xenetic Biosciences, Inc. (NASDAQ:XBIO) gained 13.8% to close at $3.94.
Evolv Technologies Holdings, Inc. (NASDAQ:EVLV) rose 13.8% to close at $9.51. Evolv Technologies is expected to release Q2 results on August 16, 2021.
MyMD Pharmaceuticals, Inc. (NASDAQ:MYMD) gained 13.8% to close at $5.46. MyMD Pharmaceuticals’ subsidiary Oravax Medical is preparing to commence clinical trials for oral Covid-19 vaccine.
Moxian, Inc (NASDAQ:MOXC) rose 13.6% to close at $7.96.
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) gained 12.7% to close at $30.16 after reporting upbeat quarterly results. Harmony Biosciences and Blackstone entered into Strategic financing collaboration for up to $330 million.
TimkenSteel Corporation (NYSE:TMST) rose 11.2% to close at $16.88.
Lithium Americas Corp. (NYSE:LAC) jumped 11.1% to close at $17.18.
Array Technologies, Inc. (NASDAQ:ARRY) rose 10.7% to close at $15.18. Roth Capital analyst Philip Shen upgraded Array Technologies to Buy from Neutral with a $25 price target, implying an upside of 82.3%.
AerSale Corporation (NASDAQ:ASLE) gained 10.6% to close at $12.83. AerSale, last week, reported second-quarter revenue growth of 102.7% year-over-year to $91.91 million, beating the consensus of $77.28 million.
Express, Inc. (NYSE:EXPR) rose 10.3% to close at $6.31.
Model N, Inc. (NASDAQ:MODN) gained 10.1% to close at $35.88 after the company reported upbeat Q3 results and issued strong Q4 forecast.
Dynatronics Corporation (NASDAQ:DYNT) climbed 8.5% to close at $1.41 after the company reported strong preliminary sales for the fourth quarter.
The Trade Desk, Inc. (NASDAQ:TTD) climbed 7.6% to close at $87.53. Several analysts raised their price targets on Trade Desk.
Kansas City Southern (NYSE:KSU) rose 7.5% to close at $289.75 following a report suggesting Canadian Pacific plans a new higher bid for the company, near $300 per share.
Purple Innovation, Inc. (NASDAQ:PRPL) rose 7.4% to close at $26.57 after the company swung to a profit in the second quarter. The company also issued FY21 sales guidance.
Calliditas Therapeutics AB (NASDAQ:CALT) gained 7% to close at $31.68. The FDA granted Fast Track Designation to Calliditas Therapeutics lead NOX inhibitor candidate setanaxib for primary biliary cholangitis (PBC).
Lufax Holding Ltd (NYSE:LU) rose 6.4% to close at $7.96 after reporting upbeat quarterly earnings.
Allied Healthcare Products, Inc. (NASDAQ:AHPI) shares gained 6.2% to close at $10.75 after jumping around 23% on Monday.
Turning Point Therapeutics, Inc. (NASDAQ:TPTX) rose 5.6% to close at $65.57 following Q2 earnings.
Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) shares gained 4.9% to close at $50.58 after the company reported better-than-expected Q2 earnings and also said ARCT-021 will begin multinational placebo-controlled Phase 3 efficacy study funded & sponsored by a global entity.

Check out these big penny stock gainers and losers

Losers

Katapult Holdings, Inc. (NASDAQ:KPLT) shares tumbled 56.2% to close at $4.26 on Tuesday after the company reported Q2 earnings results.
Impel NeuroPharma, Inc. (NASDAQ:IMPL) fell 25.9% to close at $19.37. The company recently reported publication of pivotal Phase 3, open-label Stop 301 study of INP104 (TRUDHESA) for treatment of acute migraine in The Journal Headache.
SmileDirectClub, Inc. (NASDAQ:SDC) fell 24.2% to close at $5.08 after the company reported worse-than-expected Q2 results and issued FY21 sales guidance below estimates.
Waitr Holdings Inc. (NASDAQ:WTRH) dropped 23.3% to close at $1.22 after the company reported downbeat Q2 results. The company also reported the purchase of ProMerchant LLC, Cape Cod Merchant Services LLC and Flow Payments LLC.
Metromile, Inc. (NASDAQ:MILE) shares fell 22.5% to settle at $5.40 after the company reported a wider-than-expected Q2 loss.
comScore, Inc. (NASDAQ:SCOR) declined 22.5% to close at $3.12 after the company reported a wider-than-expected Q2 loss.
Stereotaxis, Inc. (NASDAQ:STXS) fell 21.3% to settle at $7.15 after the company reported Q2 earnings results.
Sphere 3D Corp. (NASDAQ:ANY) dropped 20.7% to close at $4.28 amid profit taking after the stock surged in recent sessions following last week's news the company will acquire exclusive rights for the assignment of cryptocurrency mining assets.
EyeGate Pharmaceuticals, Inc. (NASDAQ:EYEG) shares dropped 20.5% to close at $1.8050 after the company announced a $10.75 million registered direct offering priced at-the-market under Nasdaq rules.
PARTS iD, Inc. (NYSE:ID) fell 19.7% to close at $5.79 following weaker-than-expected Q2 results.
Yalla Group Limited (NYSE:YALA) shares dropped 18.9% to close at $10.99 following weak quarterly sales.
Talkspace, Inc. (NASDAQ:TALK) declined 18.7% to close at $4.82 following Q2 loss.
Reata Pharmaceuticals, Inc. (NASDAQ:RETA) dipped 18.1% to close at $100.00 after the company reported Q2 earnings and provided an update on clinical development programs.
The RealReal, Inc. (NASDAQ:REAL) fell 18% to close at $13.31 after the company reported worse-than-expected Q2 results.
Liminal BioSciences Inc. (NASDAQ:LMNL) fell 17.8% to close at $3.00. Liminal BioSciences jumped around 28% on Monday as the company said its subsidiary Prometic Biotherapeutics Inc. entered into a definitive agreement to sell its Rare Pediatric Disease Priority Review Voucher for USD105 million.
Mercurity Fintech Holding Inc. (NASDAQ:MFH) dropped 17% to settle at $3.42 amid a rise in yields, which has weighed on tech and growth stocks.
Casper Sleep Inc. (NYSE:CSPR) declined 16.8% to close at $5.76 after reporting a wider-than-expected quarterly loss.
Lucira Health, Inc. (NASDAQ:LHDX) fell 16.8% to settle at $8.25.
Star Equity Holdings, Inc. (NASDAQ:STRR) fell 16.2% to close at $3.00 after the company posted a wider quarterly loss.
ZIOPHARM Oncology, Inc. (NASDAQ:ZIOP) declined 162.% to settle at $1.92 after the company reported Q2 earnings results. Following earnings, Raymond James downgraded the stock from Outperform to Market Perform and announced a $3 price target.
SCWorx Corp. (NASDAQ:WORX) fell 16% to settle at $3.21.
Washington Prime Group Inc. (NYSE:WPG) fell 15.5% to settle at $1.42 after the company reported Q2 earnings results.
AeroCentury Corp. (NYSE:ACY) dropped 15% to close at $17.07.
CarLotz, Inc. (NASDAQ:LOTZ) fell 14.3% to close at $4.03 after the company reported it withdrew previously-issued FY21 guidance, citing "channel constraints."
FedNat Holding Company (NASDAQ:FNHC) dipped 14.1% to close at $2.19 after reporting a wider quarterly loss.
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) shares fell 13.9% to close at $15.21 after the company announced it commenced a public offering of $200 million of common stock and pre-funded warrants.
X Financial (NYSE:XYF) dropped 13.9% to close at $6.81 following Q2 results.
UpHealth, Inc. (NYSE:UPH) fell 13.5% to close at $5.38. UpHealth is expected to release quarterly results on August 12, 2021.
Home Point Capital Inc. (NASDAQ:HMPT) dropped 13.5% to close at $4.56 after reporting a Q2 loss.
Nano-X Imaging Ltd. (NASDAQ:NNOX) fell 13.4% to settle at $26.07 after the company reported Q2 results and announced plans to acquire Zebra Medical Vision.
Oak Street Health, Inc. (NYSE:OSH) fell 12.9% to settle at $54.81 after the company reported worse-than-expected Q2 EPS results.
Origin Agritech Limited (NASDAQ:SEED) fell 12.5% to settle at $11.83.
CareMax, Inc. (NASDAQ:CMAX) fell 12% to settle at $8.35.
Aterian, Inc. (NASDAQ:ATER) dipped 11.5% to close at $4.86. Aterian S-1 showed registration for 2.7 million share common stock offering via selling shareholders. Roth Capital downgraded Aterian from Buy to Neutral and announced a $5.5 price target.
Fulgent Genetics, Inc. (NASDAQ:FLGT) shares slipped 11.3% to close at $97.34 after the company reported worse-than-expected Q2 results. Fulgent Genetics and Helio Health also reported a partnership to commercialize early cancer detection tests.
Inovio Pharmaceuticals, Inc. (NASDAQ:INO) fell 10.8% to settle at $8.57 after the company reported worse-than-expected Q2 results.
AudioEye, Inc. (NASDAQ:AEYE) fell 7.8% to close at $13.33. The company is expected to release quarterly earnings on August 11, 2021.
Vuzix Corporation (NASDAQ:VUZI) fell 7.2% to close at $12.73 after the company reported worse-than-expected Q2 results.
Senseonics Holdings, Inc. (NYSE:SENS) shares fell 6.5% to close at $3.04 after the company reported Q2 earnings results and issued FY21 guidance.
Cano Health, Inc. (NYSE:CANO) fell 6.2% to close at $10.94.
Nautilus, Inc. (NYSE:NLS) fell 5.4% to close at $13.56. Nautilus reported first-quarter FY22 sales growth of 61.7% year-on-year. Craig-Hallum downgraded Nautilus from Buy to Hold.